Webinar: Recent Developments in Biosimilars Settlements, Market Landscape and Antitrust Scrutiny

March 20, 2019

Heather Schneider and Tara Thieme spoke on a webinar panel co-hosted by Willkie and Taylor Wessing in a four-part webinar series covering various aspects of biosimilars litigation, market access and regulation.

Session 1 of this series focused on key factors decision makers need to be aware of when considering settlement, including:

  • Recent biosimilars settlement agreements in the U.S. and Europe
  • Legal requirements driving settlement in Europe
  • FTC scrutiny of biosimilars settlements in the U.S.

To listen to a recording of the event, please click here.